{"entity":{"type":"insider","cik":"0001458506","url":"/insider/0001458506","json_url":"/insider/0001458506.json","name":"Hamdy Ahmed MD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2010-10-07","last":"2023-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Hamdy Ahmed MD","source":"filing","n_filings":6,"first_seen":"2010-10-07","last_seen":"2023-08-10"}],"transactions":[{"id":8530365,"accession":"0000950170-23-041517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-041517","line_url":"/filing/0000950170-23-041517#line-2","is_derivative":false,"issuer_cik":"0001458506","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001458506","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5400.0,"shares_display":"5,400","price_per_share":0.9569,"price_display":"0.96","price_state":"stated","total_value":5167.26,"total_display":"5,167.26","shares_owned_after":96060.0,"shares_owned_after_display":"96,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-10","scope":"insider"},{"id":8530361,"accession":"0000950170-23-041517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-041517","line_url":"/filing/0000950170-23-041517#line-1","is_derivative":false,"issuer_cik":"0001458506","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001458506","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Director, Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16900.0,"shares_display":"16,900","price_per_share":0.9464,"price_display":"0.95","price_state":"stated","total_value":15994.16,"total_display":"15,994.16","shares_owned_after":90660.0,"shares_owned_after_display":"90,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-10","scope":"insider"},{"id":6264683,"accession":"0000899243-22-038529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038529","line_url":"/filing/0000899243-22-038529#line-1","is_derivative":false,"issuer_cik":"0001458506","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001458506","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35280.0,"shares_display":"35,280","price_per_share":0.8656,"price_display":"0.87","price_state":"stated","total_value":30538.368,"total_display":"30,538.37","shares_owned_after":73760.0,"shares_owned_after_display":"73,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-14","scope":"insider"},{"id":6089453,"accession":"0000899243-22-024247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024247","line_url":"/filing/0000899243-22-024247#line-1","is_derivative":false,"issuer_cik":"0001458506","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001458506","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24200.0,"shares_display":"24,200","price_per_share":1.4106,"price_display":"1.41","price_state":"stated","total_value":34136.52,"total_display":"34,136.52","shares_owned_after":38480.0,"shares_owned_after_display":"38,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-27","scope":"insider"},{"id":5432443,"accession":"0000899243-21-049763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-049763","line_url":"/filing/0000899243-21-049763#line-1","is_derivative":false,"issuer_cik":"0001458506","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001458506","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6450.0,"shares_display":"6,450","price_per_share":10.0232,"price_display":"10.02","price_state":"stated","total_value":64649.64,"total_display":"64,649.64","shares_owned_after":14280.0,"shares_owned_after_display":"14,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-27","scope":"insider"},{"id":4123048,"accession":"0000899243-21-026820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-026820","line_url":"/filing/0000899243-21-026820#line-1","is_derivative":false,"issuer_cik":"0001458506","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001458506","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7830.0,"shares_display":"7,830","price_per_share":12.77,"price_display":"12.77","price_state":"stated","total_value":99989.1,"total_display":"99,989.10","shares_owned_after":7830.0,"shares_owned_after_display":"7,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-06-30","scope":"insider"},{"id":7281589,"accession":"0001209191-10-049658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-049658","line_url":"/filing/0001209191-10-049658#line-2","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":"0001458506","owner_name":"Hamdy Ahmed MD","owner_url":"/insider/0001458506","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":123000.0,"total_display":"123,000.00","shares_owned_after":2010.0,"shares_owned_after_display":"2,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-05","filed_date":"2010-10-07","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796129","name":"Vincerx Pharma, Inc.","url":"/issuer/0001796129","role":"Director, Officer","n_filings":5,"first_seen":"2021-06-30","last_seen":"2023-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000949699","name":"PHARMACYCLICS INC","url":"/issuer/0000949699","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2010-10-07","last_seen":"2010-10-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001458506","retrieved_at":"2026-08-21T03:51:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}